NeuroPace (NPCE) Competitors $9.19 +0.01 (+0.11%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NPCE vs. SMTI, CVRX, UTMD, TCMD, TELA, ESTA, PLSE, BLFS, BVS, and CBLLShould you be buying NeuroPace stock or one of its competitors? The main competitors of NeuroPace include Sanara MedTech (SMTI), CVRx (CVRX), Utah Medical Products (UTMD), Tactile Systems Technology (TCMD), TELA Bio (TELA), Establishment Labs (ESTA), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Bioventus (BVS), and CeriBell (CBLL). These companies are all part of the "medical" sector. NeuroPace vs. Sanara MedTech CVRx Utah Medical Products Tactile Systems Technology TELA Bio Establishment Labs Pulse Biosciences BioLife Solutions Bioventus CeriBell NeuroPace (NASDAQ:NPCE) and Sanara MedTech (NASDAQ:SMTI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, community ranking, analyst recommendations, profitability, earnings and media sentiment. Does the media refer more to NPCE or SMTI? In the previous week, NeuroPace had 7 more articles in the media than Sanara MedTech. MarketBeat recorded 11 mentions for NeuroPace and 4 mentions for Sanara MedTech. Sanara MedTech's average media sentiment score of 0.98 beat NeuroPace's score of 0.85 indicating that Sanara MedTech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeuroPace 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Sanara MedTech 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation & earnings, NPCE or SMTI? Sanara MedTech has lower revenue, but higher earnings than NeuroPace. Sanara MedTech is trading at a lower price-to-earnings ratio than NeuroPace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroPace$65.42M4.19-$32.96M-$1.00-9.19Sanara MedTech$64.99M5.01-$4.30M-$0.99-37.66 Which has more risk and volatility, NPCE or SMTI? NeuroPace has a beta of 1.79, suggesting that its share price is 79% more volatile than the S&P 500. Comparatively, Sanara MedTech has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500. Is NPCE or SMTI more profitable? Sanara MedTech has a net margin of -10.71% compared to NeuroPace's net margin of -36.74%. Sanara MedTech's return on equity of -19.86% beat NeuroPace's return on equity.Company Net Margins Return on Equity Return on Assets NeuroPace-36.74% -205.41% -28.29% Sanara MedTech -10.71%-19.86%-10.91% Do analysts rate NPCE or SMTI? NeuroPace presently has a consensus target price of $14.60, suggesting a potential upside of 58.87%. Sanara MedTech has a consensus target price of $44.00, suggesting a potential upside of 18.03%. Given NeuroPace's higher possible upside, analysts plainly believe NeuroPace is more favorable than Sanara MedTech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroPace 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in NPCE or SMTI? 78.8% of NeuroPace shares are held by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are held by institutional investors. 22.2% of NeuroPace shares are held by company insiders. Comparatively, 54.1% of Sanara MedTech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community believe in NPCE or SMTI? NeuroPace received 9 more outperform votes than Sanara MedTech when rated by MarketBeat users. Likewise, 57.45% of users gave NeuroPace an outperform vote while only 54.55% of users gave Sanara MedTech an outperform vote. CompanyUnderperformOutperformNeuroPaceOutperform Votes2757.45% Underperform Votes2042.55% Sanara MedTechOutperform Votes1854.55% Underperform Votes1545.45% SummaryNeuroPace and Sanara MedTech tied by winning 9 of the 18 factors compared between the two stocks. Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get NeuroPace News Delivered to You Automatically Sign up to receive the latest news and ratings for NPCE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NPCE vs. The Competition Export to ExcelMetricNeuroPaceSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$274.01M$4.46B$5.05B$8.87BDividend YieldN/A36.76%4.97%4.06%P/E Ratio-9.1914.8997.3414.18Price / Sales4.1947.261,218.4289.42Price / CashN/A52.2233.5132.79Price / Book27.855.475.805.12Net Income-$32.96M$13.76M$119.07M$225.99M7 Day Performance-5.06%-1.08%-1.83%-1.32%1 Month Performance48.23%0.58%-3.64%0.60%1 Year Performance6.86%50.91%31.62%26.23% NeuroPace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NPCENeuroPace3.7719 of 5 stars$9.19+0.1%$14.60+58.9%+5.6%$274.01M$65.42M-9.19170Analyst RevisionSMTISanara MedTech1.2151 of 5 stars$37.28+0.9%$44.00+18.0%+17.2%$322.99M$64.99M0.0060Gap UpHigh Trading VolumeCVRXCVRx2.0918 of 5 stars$13.52+0.7%$15.83+17.1%-25.8%$328.05M$47.26M-5.01200UTMDUtah Medical Products3.4454 of 5 stars$64.18-0.8%N/A-23.5%$219.40M$50.22M15.03180Positive NewsTCMDTactile Systems Technology3.7846 of 5 stars$15.56-1.3%$23.00+47.8%+23.1%$378.43M$274.42M23.94980TELATELA Bio3.7058 of 5 stars$2.90-0.3%$9.25+219.0%-40.5%$114.62M$58.45M0.00120ESTAEstablishment Labs2.1311 of 5 stars$41.81+11.4%$60.60+44.9%+90.0%$1.05B$165.15M0.00960High Trading VolumePLSEPulse Biosciences1.5329 of 5 stars$16.14-5.3%N/A+157.8%$1.05B$700,000.000.00140Positive NewsBLFSBioLife Solutions0.8729 of 5 stars$25.01+11.5%$27.50+10.0%+86.5%$1.04B$146.96M-23.59409Analyst ForecastInsider TradeAnalyst RevisionHigh Trading VolumeBVSBioventus2.7241 of 5 stars$11.41-1.6%$13.00+13.9%+195.6%$925.98M$555.06M-18.701,200Positive NewsCBLLCeriBellN/A$25.06-2.0%$31.20+24.5%N/A$897.65MN/A0.00N/AQuiet Period ExpirationAnalyst Revision Related Companies and Tools Related Companies Sanara MedTech Alternatives CVRx Alternatives Utah Medical Products Alternatives Tactile Systems Technology Alternatives TELA Bio Alternatives Establishment Labs Alternatives Pulse Biosciences Alternatives BioLife Solutions Alternatives Bioventus Alternatives CeriBell Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NPCE) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroPace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroPace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
